Polaris Pharmaceuticals Competitors and Similar CompaniesClear all
Polaris Pharmaceuticals's competitors and similar companies include Infinity Pharmaceuticals, Onconova Therapeutics, Processa Pharmaceuticals and HCW Biologics.
 Polaris Pharmaceuticals Polaris Pharmaceuticals is a biopharmaceutical drug company focused on developing anti-cancer therapies. |  Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions. |  Onconova Therapeutics Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer. |  Processa Pharmaceuticals Processa Pharmaceuticals (formerly Heatwurx) is a company focused on developing treatments for patients with an unmet medical need. |  HCW Biologics HCW Biologics is a company developing proprietary immunotherapy candidates to address chronic inflammation through inflammasome modulation and senescent cell reduction. | |
Founding Date | Founding Date 2006 | Founding Date 2000 | Founding Date 1998 | Founding Date 2017 | Founding Date 2018 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ Vacaville, US | Locations Cambridge, US HQ | Locations Newtown, US HQ Boston, US Newtown, US Pennington, US | Locations Hanover, US HQ | Locations Miramar, US HQ |
Employees | Employees 26 | Employees 25 | Employees 1732% decrease | Employees 1033% decrease | Employees 40 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 726.1 k | Valuation ($) 20.9 m | Valuation ($) 4.4 m | Valuation ($) 16.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.6m (FY, 2022) | Revenue (est.) $2.8m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $54.2k (FY, 2025) |
Net income | Net income N/A | Net income ($44.4m) (FY, 2022) | Net income $9.2m (FY, 2024) | Net income ($13.6m) (FY, 2025) | Net income ($8m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 106.6m | Total funding raised $ 88m | Total funding raised N/A | Total funding raised $ 24.3m |
For sources of this data, please see the company profile
View Company Profiles
Infinity Pharmaceuticals
HQ
Cambridge, US
Employees
25
Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
View companyOnconova Therapeutics
HQ
Newtown, US
Employees
17↓ 32% decrease
Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer.
View companyProcessa Pharmaceuticals
HQ
Hanover, US
Employees
10↓ 33% decrease
Processa Pharmaceuticals (formerly Heatwurx) is a company focused on developing treatments for patients with an unmet medical need.
View companyHCW Biologics
HQ
Miramar, US
Employees
40
HCW Biologics is a company developing proprietary immunotherapy candidates to address chronic inflammation through inflammasome modulation and senescent cell reduction.
View company